CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Eric Linsley will co-chair the CED's 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
